Vita 34 AG
XHAM:V3V
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
V
|
Vita 34 AG
XHAM:V3V
|
DE |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
CA |
|
V
|
Valero Energy Corp
F:V1L
|
US |
|
Distribuidora Internacional de Alimentacion SA
OTC:DIDAF
|
ES |
|
V
|
Valeura Energy Inc
F:83PN
|
CA |
|
L
|
Legrand SA
XMUN:LRC
|
FR |
|
Subsea 7 SA
F:SOCA
|
UK |
|
Fanuc Corp
OTC:FANUY
|
JP |
|
Sequana Medical NV
XBRU:SEQUA
|
BE |
|
T
|
TopBuild Corp
F:28T
|
US |
|
Perimeter Solutions SA
F:6OL
|
LU |
|
Compass Group PLC
LSE:CPG
|
UK |
|
A
|
ArcelorMittal SA
F:ARRD
|
LU |
Wall St Price Targets
V3V Price Targets Summary
Vita 34 AG
According to Wall Street analysts, the average 1-year price target for V3V is 7.57 EUR with a low forecast of 7.49 EUR and a high forecast of 7.79 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is V3V's stock price target?
Price Target
7.57
EUR
According to Wall Street analysts, the average 1-year price target for V3V is 7.57 EUR with a low forecast of 7.49 EUR and a high forecast of 7.79 EUR.
What is the Revenue forecast for Vita 34 AG?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Revenue has been 12%. The projected CAGR for the next 9 years is 4%.
What is the Gross Profit forecast for Vita 34 AG?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 8%. The projected CAGR for the next 4 years is 10%.
